On September 19, the Food and Drug Administration (FDA) approved Keytruda Qlex, an injectable formulation of the widely used immune checkpoint inhibitor pembrolizumab. The European Medicines Agency ...

Although “ liquid biopsies ” have gained attention for their potential to detect multiple cancers in their earliest stages, it’s too soon to tell whether the innovative blood tests are accurate and ...

According to their results, 38% of patients were prescribed at least one GO-PIMs, most-commonly selective serotonin reuptake inhibitors (SSRIs). Each additional GO-PIM was associated with a 66% ...

The details on the registration page are quite broad and they don’t show the duration of the event, nor a specific schedule of when individual topics will be covered. Even so, it may be worth ...

The researchers gave subjects challenging memory tests, including one called the backward digit span task, in which they would hear a list of up to nine digits and then try to repeat them in reverse ...

These 2025 Damon Runyon cancer research fellows study bone-deep pain, bacterial secretions, re-engineered viruses, gamma delta T cells and more.

Stroke was the fourth leading cause in 2024, at 166,783 deaths. When combined with heart disease, cardiovascular causes are responsible for an overwhelming share of U.S. mortality. Despite ...

Black communities across the United States experience significantly high rates of colorectal cancer —about 20% to 30% higher than their white counterparts. How to better understand and address these ...

Every year the second Saturday of October marks World Hospice and Palliative Care Day (WHPCD). This year WHPCD will be on Saturday 11 October 2025. Each year the WHPCD campaign has a theme that is ...

SARS-CoV-2, the virus that causes COVID-19, and other respiratory infections can awaken latent breast cancer cells that have spread to the lungs, potentially raising the risk for relapse, according to ...

First-line treatment with Enhertu plus Perjeta (pertuzumab) reduced the risk of disease progression or death by 44% for patients with HER2-positive advanced breast cancer, while Trodelvy plus Keytruda ...

Radiation may shrink existing metastatic tumors not directly treated. New research shows the opposite effect: Such tumors may also grow.